MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development
By Bryan in Business
Updated 3 years ago
NEW YORK, May 13, 2021 /CNW/ -- MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic-inspired medicine company has appointed Peter Mack PhD as Vice President of Pharmaceutical Development. As MindMed progresses it's Discover and Develop efforts for multiple commercial clinical programs including LSD and an ibogaine derivative, 18-MC,...
